Cargando…

SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment

BACKGROUND: Test the ability of Mirasol Pathogen Reduction Technology (PRT, Terumo BCT, Lakewood Co, USA) treatment with riboflavin and ultraviolet light (R + UV) in reducing SARS-CoV-2 infectivity while maintaining blood product quality. MATERIAL AND METHODS: SARS-CoV-2 strains were isolated and ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrari, Alessandro, Cassaniti, Irene, Sammartino, Josè Camilla, Mortellaro, Cristina, Del Fante, Claudia, De Vitis, Simona, Barone, Eugenio, Troletti, Daniela, Prati, Federica, Baldanti, Fausto, Percivalle, Elena, Cesare, Perotti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847076/ https://www.ncbi.nlm.nih.gov/pubmed/35227599 http://dx.doi.org/10.1016/j.transci.2022.103398

Ejemplares similares

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Experimental studies on the inactivation of HBV in blood via riboflavin photochemical treatment
por: Zhou, Zi-Yu, et al.
Publicado: (2017)

Evaluation of the inactivation effect of riboflavin photochemical method on duck hepatitis B virus
por: Zhou, Zi-Yu, et al.
Publicado: (2018)

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
por: Keil, Shawn D., et al.
Publicado: (2020)

Macrophages and Monocytes: “Trojan Horses” in COVID-19
por: Percivalle, Elena, et al.
Publicado: (2021)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region
por: Percivalle, Elena, et al.
Publicado: (2021)

Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
por: Perotti, Cesare, et al.
Publicado: (2020)

The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale
por: Mirshafiee, Hamideh, et al.
Publicado: (2015)

Evaluation of riboflavin photochemical treatment for inactivation of HCT116 tumor cells mixed in simulative intraoperative salvage blood
por: Yu, Yang, et al.
Publicado: (2019)

In vitro antimicrobial efficacy of riboflavin, ultraviolet-A radiation, and combined riboflavin/ultraviolet-A radiation on ocular pathogens
por: Sharma, Ashok, et al.
Publicado: (2021)

Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020)

Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study
por: Sammartino, José Camilla, et al.
Publicado: (2023)

Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns
por: Cassaniti, Irene, et al.
Publicado: (2021)

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
por: Cassaniti, Irene, et al.
Publicado: (2022)

Inactivation of model viruses and bacteria in human fresh frozen plasma using riboflavin and long wave ultraviolet rays
por: Elikaei, Ameneh, et al.
Publicado: (2017)

Effects of photochemical riboflavin-mediated crosslinks on the physical properties of collagen constructs and fibrils
por: Rich, Harvey, et al.
Publicado: (2013)

Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus
por: El-Raggal, Tamer M.
Publicado: (2009)

mRNA BNT162b Vaccine Elicited Higher Antibody and CD4(+) T-Cell Responses than Patients with Mild COVID-19
por: Zavaglio, Federica, et al.
Publicado: (2022)

Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers
por: Khan, Muhammad S., et al.
Publicado: (2023)

Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers
por: Khan, Muhammad S., et al.
Publicado: (2023)

Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection
por: Zavattoni, Maurizio, et al.
Publicado: (2019)

Patient Blood Management after Hematopoietic Stem Cell Transplantation in a Pediatric Setting: Starting Low and Going Lower
por: Del Fante, Claudia, et al.
Publicado: (2023)

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
por: Cassaniti, Irene, et al.
Publicado: (2021)

Tuning riboflavin derivatives for photodynamic inactivation of pathogens
por: Crocker, Leander B., et al.
Publicado: (2022)

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
por: Lanteri, Marion C., et al.
Publicado: (2020)

Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection
por: Gregorini, Marilena, et al.
Publicado: (2021)

West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors
por: Percivalle, Elena, et al.
Publicado: (2020)

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
por: Cassaniti, Irene, et al.
Publicado: (2022)

Conjunctival Ultraviolet Autofluorescence as a Measure of Riboflavin and Ultraviolet and Accelerated Cross-Linking Exposure in Keratoconic Patients
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial
por: Perotti, Cesare, et al.
Publicado: (2020)

Analysis of riboflavin/ultraviolet a corneal cross-linking by molecular spectroscopy
por: Melcher, Steven, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
por: Cassaniti, Irene, et al.
Publicado: (2021)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Comment on: Corneal collagen cross-linking with riboflavin and ultraviolet: A light for keratoconus
por: Parthasarathy, Anand
Publicado: (2010)

Ultraviolet-A Light and Riboflavin Therapy for Acanthamoeba Keratitis: A Case Report
por: Garduño-Vieyra, Leopoldo, et al.
Publicado: (2011)

Comparison of Riboflavin/Ultraviolet-A Cross-Linking in Porcine, Rabbit, and Human Sclera
por: Zhang, Yali, et al.
Publicado: (2014)

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
por: Rovida, Francesca, et al.
Publicado: (2021)

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
por: Lasagna, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4r06takram02g1shq8v5apkdve